In addition, we divided NSCLC patients into three subgroups based on their expression levels: double-high (co-expression of SOX4 and BMI1), single-high (high expression of either SOX4 or BMI1), and double-low (low expression of both SOX4 and BMI1). The gene discussed is SOX4; the disease is non-small cell lung carcinoma.